Reference health
Clinical Significance of B7-H3 and HER2 Co-Expression and Therapeutic Value of Combination Treatment in Gastric Cancer
1 of 40 checkable references need attention · checked 2026-07-23
At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.
10 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
References needing attention
marked retracted — notice via Crossref, record curated by Retraction Watch10.3892/or.2014.3405
Aberrant expression of B7-H3 in gastric adenocarcinoma promotes cancer cell metastasis
The 39 checked references that resolve
resolves10.3322/caac.21660
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
resolves10.1016/S1470-2045(13)70436-4
Management of gastric cancer in Asia: resource-stratified guidelines
resolves10.1093/jnci/djw166
The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysis
resolves10.1080/14789450.2016.1246189
Proteomics approach to identify biomarkers for upper gastrointestinal cancer
resolves10.1016/S1470-2045(08)70035-4
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
resolves10.1016/S0140-6736(10)61121-X
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
resolves10.3748/wjg.v22.i23.5406
Association of HER2 status with prognosis in gastric cancer patients undergoing R0 resection: A large-scale multicenter study in China
resolves10.1158/1078-0432.CCR-15-2428
Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy
resolves10.1111/j.1349-7006.2011.01877.x
B7‐H3 expression in gastric cancer: A novel molecular blood marker for detecting circulating tumor cells
resolves10.7150/thno.43991
Tandem CAR-T cells targeting CD70 and B7-H3 exhibit potent preclinical activity against multiple solid tumors
resolves10.3389/fonc.2019.01466
Overexpression of B7-H3 in α-SMA-Positive Fibroblasts Is Associated With Cancer Progression and Survival in Gastric Adenocarcinomas
resolves10.2174/156800908785133141
The Immunoregulatory Protein Human B7H3 is a Tumor-Associated Antigen that Regulates Tumor Cell Migration and Invasion
resolves10.1158/1535-7163.MCT-11-0072
B7-H3 Silencing Increases Paclitaxel Sensitivity by Abrogating Jak2/Stat3 Phosphorylation
resolves10.1002/ijc.26238
B7‐H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis‐associated genes
resolves10.7150/jca.17759
B7-H3 Promotes the Migration and Invasion of Human Bladder Cancer Cells via the PI3K/Akt/STAT3 Signaling Pathway
resolves10.1016/S1470-2045(20)30326-0
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22–05): a single-arm, phase 1b–2 trial
resolves10.1038/s41586-021-04161-3
The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer
resolves10.1158/1078-0432.CCR-16-3107
B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes
resolves10.1007/s00262-012-1278-5
B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence
resolves10.1038/sj.onc.1210477
The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis
resolves10.1016/j.drup.2018.03.001
How the Warburg effect supports aggressiveness and drug resistance of cancer cells?
resolves10.1111/j.1582-4934.2008.00540.x
Osteopontin promotes gastric cancer metastasis by augmenting cell survival and invasion through Akt‐mediated HIF‐1α up‐regulation and MMP9 activation
resolves10.1016/S0140-6736(17)31827-5
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
resolves10.1200/JCO.2019.37.18_suppl.LBA4007
Pembrolizumab with or without chemotherapy versus chemotherapy for advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: The phase III KEYNOTE-062 study.
resolves10.1007/s10120-018-00909-5
Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study
resolves10.2217/fon-2020-0737
First-Line Pembrolizumab/Placebo Plus Trastuzumab and Chemotherapy in Her2-Positive Advanced Gastric Cancer: KEYNOTE-811
resolves10.1038/s41423-019-0305-2
Tumor-expressed B7-H3 mediates the inhibition of antitumor T-cell functions in ovarian cancer insensitive to PD-1 blockade therapy
resolves10.1038/cr.2017.90
Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function
resolves10.1158/1535-7163.MCT-20-0116
Preclinical Development of MGC018, a Duocarmycin-based Antibody–drug Conjugate Targeting B7-H3 for Solid Cancer
The 10 references without a DOI — listed, not checked
no DOI — not checkedRelationship between HER2 expression and tumor interstitial angiogenesis in primary gastric cancer and its effect on prognosis
no DOI — not checkedB7-H3 is overexpressed in patients suffering osteosarcoma and associated with tumor aggressiveness and metastasis
no DOI — not checkedB7-H3 regulates KIF15-activated ERK1/2 pathway and contributes to radioresistance in colorectal cancer
no DOI — not checkedDNMT1 recruited by EZH2-mediated silencing of miR-484 contributes to the malignancy of cervical cancer cells through MMP14 and HNF1A
no DOI — not checkedThe clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature
no DOI — not checkedSoluble B7-H3 promotes the invasion and metastasis of pancreatic carcinoma cells through the TLR4/NF-?B pathway
no DOI — not checkedCancer cell-expressed B7-H3 regulates the differentiation of tumor-associated macrophages in human colorectal carcinoma
no DOI — not checkedInhibition of CD133 Overcomes Cisplatin Resistance Through Inhibiting PI3K/AKT/mTOR Signaling Pathway and Autophagy in CD133-Positive Gastric Cancer Cells
no DOI — not checkedImpact of OCT4 and Its Related Signaling Pathways on Gastrointestinal Cancers: Focusing on Targeted Therapy
no DOI — not checkedB7-H3 inhibits the IFN-?-dependent cytotoxicity of V?9V?2 T cells against colon cancer cells
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.2139/ssrn.4095072"><img src="https://citestamp.com/citestamped/10.2139/ssrn.4095072/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.2139/ssrn.4095072)